Before the drug development process commences, scientists conduct computational studies, cellular assays, and genomic and proteomic research to identify a specific target molecule, such as an RNA ...

AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous ...

Proteins have specific biological functions in cells through conformational changes and interactions. Therefore, precise, in ...

FDA's plan to phase out animal testing may hurt Charles River's revenues. The DCF model suggests that CRL presents an ...

The acquisition will expand AbbVie's exploration of in vivo CAR-T therapy, an ambitious approach that could sidestep some of ...

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

An AI-enabled drug discovery approach identified a potentially game-changing treatment for Rett syndrome, which has been ...

AI-enabled drug discovery approach identified potentially game-changing treatment which has been advanced from the lab bench to an FDA Orphan Drug ...

An international research team, including scientists from the Institut de Neurociències at the Universitat Autònoma de ...

This process is known as metabolic glycan labeling and has shown promise in targeted drug delivery systems. Wang's lab had previously demonstrated successful metabolic labeling in cancer and ...

The entire process can take weeks, though many companies are working on ways to make it faster and more efficient. In vivo engineering of a patient’s immune cells would avoid this expensive ...

YolTech Therapeutics, a clinical-stage biotechnology company developing in vivo genome editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's ...